Journal
HYPERTENSION IN PREGNANCY
Volume 29, Issue 1, Pages 1-9Publisher
TAYLOR & FRANCIS INC
DOI: 10.3109/10641950802629709
Keywords
Marinobufagenin; Resibufogenin; Preeclampsia; Intrauterine growth restriction
Funding
- Dialysis Clinic, Inc.
- Department of Medicine, Scott & White Memorial Hospital
- Texas A&M Health Science Center College of Medicine
Ask authors/readers for more resources
Background and Objectives. We have developed a rat model of preeclampsia which is based upon excessive volume expansion and includes hypertension, proteinuria and intrauterine growth restriction. In this model, the urinary excretion of the circulating steroid inhibitor of Na +/ K+ ATPase, marinobufagenin, is increased prior to the development of hypertension and proteinuria. An analogue of marinobufagenin, resibufogenin, successfully treats the hypertension and proteinuria. Methods. We administered resibufogenin early in pregnancy in this model, prior to the development of the syndrome. Results. We found that resibufogenin not only prevented the advent of hypertension and proteinuria, but also the development of intrauterine growth restriction. Discussion. These results may have relevance to the human condition.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available